Skip to main content

Table 4 Site specific 5-year survival when compared to treatment strategy

From: Epidemiology and outcomes of gastrointestinal mucosal melanomas: a national database analysis

Primary Site Total N One year Survival (in %) 5-year O.S. (in %)
C CRT NT R S SC SCRT SRT
N    46 30 286 59 487 82 33 80
p-value based onsite specific at 1 year    0.034 0.411 0.028 0.152 0.00 0.966 0.006 0.271
ANAL CANAL 325 48.0 18.5 25 21.3 50 45.5 11.5 23.7 32.6
ESOPHAGUS 62 32.3 0 0 8.5 27.7 11.6 0   
GALLBLADDER 19 68.4    40   61.5    
LARGE BOWEL 29 69.0 0   34.3   70    100
LIVER 1 100.0         
OTHER 6 16.7 0   25   0    
OVERLAPPING LESION OF RECTUM AND ANAL CANAL 214 49.1 31.3 0 40 25 33.6 34 14.3 22.2
PANCREAS 4 25.0    33.3   0    
RECTUM 352 41.8 0 11.2 26.4 0 31.3 18.5 44.4 34
SMALL BOWEL 52 51.9 50   0 0 54 41.7 50 0
STOMACH 39 43.6 0   18.6 0 32.1 50   
  1. N, Number; O.S, Overall survival; C, Chemotherapy only; CRT, chemotherapy plus radiotherapy; NT, No therapy; R, Radiotherapy only; S, Surgery only; SC, Surgery plus chemotherapy; SCRT, Surgery plus chemotherapy plus radiotherapy; SRT, Surgery plus chemotherapy